Greenwich LifeSciences GLSI
NASDAQ GLSI
$16.57 +0.33 (+2.03%)
At close: Oct 21, 2026 · 4:00 PM EDT

Greenwich LifeSciences (GLSI) Total Non-Current Liabilities (2024 - 2026)

Updated

Greenwich LifeSciences' Total Non-Current Liabilities was $4.56 million in Q1 2026, up 103.3% from $2.24 million a year earlier but down 11.4% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Greenwich LifeSciences came in at $5.15 million, up 78.9% from FY2024.

  • In earlier years, Total Non-Current Liabilities was $2.88 million in FY2024.
  • Quarterly Total Non-Current Liabilities has moved between $1.38 million (Q2 2025) and $5.15 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Greenwich LifeSciences 241.93 Mn 218.31 Mn - 4.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.56 Mn
Dec 31, 2025 5.15 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 2.24 Mn
Dec 31, 2024 2.88 Mn
API Access

Greenwich LifeSciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GLSI&period=max&api_key=YOUR_API_KEY